Altamira Therapeutics And Pharma Nordic Collaborate For Marketing And Distribution Of Bentrio In Scandinavia
Portfolio Pulse from Happy Mohamed
Altamira Therapeutics Ltd. (NASDAQ:CYTO) has entered into an exclusive agreement with Pharma Nordic AS for the marketing and distribution of Bentrio, a nasal spray for protection against airborne allergens, in Norway and potentially further Scandinavian countries. The collaboration agreement will allow Pharma Nordic to market and commercialize Bentrio in Norway beginning in the first quarter of 2024, and, subject to meeting certain milestones, also in Sweden, Finland, and Denmark later on.
July 20, 2023 | 12:48 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Altamira Therapeutics' partnership with Pharma Nordic for the marketing and distribution of Bentrio in Scandinavia could potentially increase the company's market reach and revenues.
The partnership with Pharma Nordic allows Altamira Therapeutics to expand the market for Bentrio to Scandinavia. This could potentially increase the company's revenues and profitability, which could positively impact the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100